Onconetix, Inc. — Director's Dealing 2023

May 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Biotech, Inc. (BWV)
CIK: 0001782107
Period of Report: 2023-05-09

Reporting Person: Garfield Jon (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-09	Common Stock	A	100000	—	Acquired	100000	Direct

Footnotes

F1: The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025.